Insightful Science Bolsters Executive Team with Senior Sales and Marketing Expertise to Accelerate Growth Initiatives

Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV).

Zelis Announces New Chief Marketing Officer, Heather Valteris, International Brand Builder and Strategist for Fortune 100 Companies

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Creative Peptides Announces Innovative Services of Peptide Drug Discovery

Creative Peptides announces the release of innovative peptide drug discovery services to support and assist global clients in winning the race of peptide drug development.

Creative Peptides Rolls Out PNA FISH Probes with High Sensitivity and Specific Hybridization

Creative Peptides rolls out a variety of PNA FISH probe products with high sensitivity and specific hybridization for worldwide customers.

Useful Approaches for Labeling Peptides with Fluorescent Dyes

Creative Peptides provides useful approaches for labeling peptides with fluorescent dyes

Lyniate and NextGate Announce Merger Agreement, Advancing Healthcare Interoperability Leadership

Lyniate and NextGate have entered into a merger agreement.

ProteoGenix Launches New XtenCHO Transient CHO Expression System to Improve Biologics Development

ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHOTM Transient Expression System.

Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal

Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal March 14, 2022 - North Carolina-based Triangle Business Journal recently unveiled the winners of its 2022 class of Health Care Leadership Awards, naming Rho as one of this year’s honorees. The global, full-service contract research organization (CRO) was chosen from a pool of Triangle-area nominees that work in a number of health care settings, including major hospital systems, small physician groups, life sciences firms and nonprofit health charities. "The honorees of this year’s Health Care Leadership Awards are making a significant impact on the quality of health care in the Triangle region," said Jason Christie, market president and publisher of TBJ. "This year’s honorees really are heroes in our community. Triangle Business Journal is pleased to honor them.”

Beckman Coulter Introduces Antipsychotic Drug Testing to Address Unmet Clinical Need for More Than 69 Million People Living with Serious Mental Conditions

Curebase Rapidly Reaches Growth Milestone

Decentralized Clinical Trial Platform Provider Welcomes 100th Teammate

Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities

Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities

PubHive Adds Auto-Scheduling for Recurring Aggregate Safety Reports

Cloud-based software platform PubHive Navigator now supports auto-scheduling of aggregate safety reports plus bulk assignments of responsible report owners

physIQ and CellCarta Collaborate to Accelerate a More Precise, Personalized Approach to Vaccine Development

physIQ, a pioneer in digital medicine, and CellCarta, a global leader in precision medicine services, announce a strategic collaboration to undertake a groundbreaking study with the potential to revolutionize vaccine development.

Curebase and CoBTeK (team from Côte d’Azur) to Collaborate on a European Clinical Trial of Remote Tools Designed to Help Seniors Retain Autonomy

Curebase and CoBTeK (team from Côte d’Azur) to Collaborate on a European Clinical Trial of Remote Tools Designed to Help Seniors Retain Autonomy

MicrobioSeq Releases PCR-based Microbial Antibiotic Resistance Gene Analysis Service

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance.

CD Genomics: Bioinformatics-Analysis Division Provides Genotyping Analysis Service for Studying Genetic Variations

CD ComputaBio Launches Homology Modeling Service for Drug Screening and Discovery

As a reliable computational biology service provider based in New York, CD ComputaBio has recently launched homology modeling service to help researchers deeply understand the structure-activity relationship of the target protein, and provide strong support for structure-based rational drug design, protein function research, and protein engineering research. Relying on its professional team and advanced technology, as well as high-quality products and services, CD ComputaBio has gained a solid reputation.

CD ComputaBio Releases Molecular Docking Service for Enzymology Research and Drug Design

CD ComputaBio, a reliable computational biology service provider located in New York, always hammers at researches and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. Recently, the product manager announced the launch of molecular docking service, which has a wide range of applications in the field of enzymology research and drug design.